Yeah... and I think we can all agree some dilution is necessary to grow a business. 95% of companies do it one way or another. The important piece to watch is HOW MUCH dilution will they continue with...
With those good margins on the coming product rollout maybe they can afford a share buyback within a year?!
Also, many other products hopefully rolling out in 2017. Fingers crossed it's the CBD Cream!
AND everyone remember... you don't get invited to the DFCON conference for no reason... these are the latest and greatest treatments for diabetic foot ulcers. Viabecline was 96% effective and only took 4 weeks to heal ulcers where people spent months recovering, or even having to amputate limbs. Viabecline had it's best results on patients with the worst case scenarios!
Ignore the BS on the board. Grab your shares and ignore the day to day volatility, or buy in later down the road when SP is 3x what it is at now. Everyone has their strategy... I plan to sell some for profit along the way, and continue to buy more as more news is released and things such as the final patent applications are submitted and approved. GLTA!
News 
Market Data 
Discover 
